To date, Cadm1 function in myeloid cells has not been established and observing its enrichment in these cells in a model of T1D may allude to a pathogenic role for Cadm1 in instigating immune cell activation and disease progression. This evidence concerns the gene CADM1 and type 1 diabetes mellitus.